x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD"s CME activities. Our topics span cardiology, diabetes, oncology, women"s health and more. And our CME library is continuously growing, every quarter.

science & medicine medicine

All Episodes

00:00:00

Targeting Resistance in EGFRm NSCLC with...

CME/CE ·

2024/09/13

Host: Helena Yu, MD The treatment of EGFR-mutated advanced non-small-cell lung cancer (NSCLC) that has progressed on EGFR TKI therapy remains a clinical challenge, as traditional therapies have yielded only modest results. However, recent findings show that targeting HER3 can produce dramatically improved clinical outcomes. Data are rapidly emerging from late-phase trials evaluating HER3-directed antibody-drug conjugate therapies, and it is thus crucial for community-based oncologists

en

00:00:00

No Symptom Left Behind: Utilizing Standardized Tools...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Diagnostic Hurdles: Recognizing and Addressing...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Beyond Monotherapy: Augmentation Strategies to Combat...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Hidden in Plain Sight: Overlapping Symptoms That...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Personalized Care: Tailoring Treatment Plans for...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Beneath the Surface: Understanding the...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Navigating Traditional Treatment Options: Current...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Empowering Patients: Enhancing Engagement for Better...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Advancing Care: Innovative Therapies for Residual...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

The Art of Adherence: Clinician Strategies for...

CME/CE ·

2024/07/15

Guest: Joseph F. Goldberg, MD Guest: Manpreet Kaur Singh, MD, MS This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

en

00:00:00

Spinal Muscular Atrophy: Optimizing the Management of...

CME/CE ·

2024/07/10

Host: Perry Shieh, MD, PhD Explore this on-demand webcast for an in-depth expert presentation and case discussion. This educational initiative is designed to help neurologists enhance their clinical approach by providing individualized, evidence-based care for adult SMA patients. Gain insights into the latest treatment options, safety and efficacy data, and effective patient communication strategies. Equip yourself with the knowledge to meet the unique clinical and psychosocial needs

en

00:00:00

From Trial to Treatment: Translating Emerging...

CME/CE ·

2024/06/28

Host: Christoph U. Correll, MD Despite the advances that have been made with atypical antipsychotics indicated for the treatment of schizophrenia (SCZ), significant safety and efficacy concerns persist with these D2 blockers. Inadequate response to these treatments is common. Several emerging agents are undergoing phase 3 clinical trials. These new treatments possess unique mechanisms of action, encouraging efficacy profiles across positive, negative, and cognitive domains and

en

00:00:00

Stratified Care: The Role of Switching or...

CME/CE ·

2024/06/28

Host: Leslie Citrome, MD, MPH Despite the advances that have been made with atypical antipsychotics indicated for the treatment of schizophrenia (SCZ), significant safety and efficacy concerns persist with these D2 blockers. Inadequate response to these treatments is common. Several emerging agents are undergoing phase 3 clinical trials. These new treatments possess unique mechanisms of action, encouraging efficacy profiles across positive, negative, and cognitive domains and favorable

en

00:00:00

D2 Antagonists Limitations and Challenges: A New Era...

CME/CE ·

2024/06/28

Host: Leslie Citrome, MD, MPH Despite the advances that have been made with atypical antipsychotics indicated for the treatment of schizophrenia (SCZ), significant safety and efficacy concerns persist with these D2 blockers. Inadequate response to these treatments is common. Several emerging agents are undergoing phase 3 clinical trials. These new treatments possess unique mechanisms of action, encouraging efficacy profiles across positive, negative, and cognitive domains and favorable

en

00:00:00

Exploring the Spectrum of Efficacy in Emerging...

CME/CE ·

2024/06/28

Host: Christoph U. Correll, MD Despite the advances that have been made with atypical antipsychotics indicated for the treatment of schizophrenia (SCZ), significant safety and efficacy concerns persist with these D2 blockers. Inadequate response to these treatments is common. Several emerging agents are undergoing phase 3 clinical trials. These new treatments possess unique mechanisms of action, encouraging efficacy profiles across positive, negative, and cognitive domains and

en

00:00:00

Case Study: What Do Augmentation and Switching...

CME/CE ·

2024/06/28

Host: Leslie Citrome, MD, MPH Despite the advances that have been made with atypical antipsychotics indicated for the treatment of schizophrenia (SCZ), significant safety and efficacy concerns persist with these D2 blockers. Inadequate response to these treatments is common. Several emerging agents are undergoing phase 3 clinical trials. These new treatments possess unique mechanisms of action, encouraging efficacy profiles across positive, negative, and cognitive domains and favorable

en

00:00:00

TRANSFORM Trial: Overview and Potential Implications

CME/CE ·

2024/06/14

Guest: Pam R. Taub, MD, FACC, FASPC Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Guest: David J. Maron, MD Explore the future of cholesterol management with cutting-edge pharmacologic therapies and the latest research on lipid-lowering treatments. Understand the transformative impact of AI in primary cardiovascular disease prevention, as highlighted by groundbreaking trials like TRANSFORM. Stay informed on how emerging therapies can help patients achieve optimal

en

00:00:00

Staging Coronary Risk: A New TRANSFORMative Approach

CME/CE ·

2024/06/14

Guest: Matthew Jay Budoff, MD Explore the future of cholesterol management with cutting-edge pharmacologic therapies and the latest research on lipid-lowering treatments. Understand the transformative impact of AI in primary cardiovascular disease prevention, as highlighted by groundbreaking trials like TRANSFORM. Stay informed on how emerging therapies can help patients achieve optimal LDL-C levels and reduce cardiovascular risks.

en

00:00:00

MACE and SGLT2 Inhibitors: Do They Have an Impact?

CME/CE ·

2024/06/14

Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Explore the future of cholesterol management with cutting-edge pharmacologic therapies and the latest research on lipid-lowering treatments. Understand the transformative impact of AI in primary cardiovascular disease prevention, as highlighted by groundbreaking trials like TRANSFORM. Stay informed on how emerging therapies can help patients achieve optimal LDL-C levels and reduce cardiovascular risks.

en

286 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事